In a Kras(G12D/WT); p53(Frt/Frt) model of lung cancer, blocking Bcl-xL activity impairs TAN ageing, thus diminishing the abundance of long-lived, tumor-supportive TANs, while preserving young TANs. Here, BCL2L1 is linked to lung carcinoma.